FridayOL

Major Breakthrough for Colon Cancer: Tecentriq Combo Slashes Recurrence and Death Risk

Reuters

A significant advancement in the fight against colon cancer has emerged from a recent study, offering new hope for patients with advanced disease. Roche's immunotherapy drug, Tecentriq, when combined with chemotherapy following surgery, has demonstr ...Read more